Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Drinking plenty of water and electrolytes can help manage this
Cardiovascular Benefits: Recent studies suggest that GLP-1 receptor agonists may provide cardiovascular benefits
Freezing the medication can cause the medication to break down and cause the medication to be less effective
Zepbound is in a class of its own as the only FDA-approved dual [gastric inhibitory polypeptide] and [glucagon-like peptide]-1 receptor agonist obesity medication, and it's changing how millions of people manage this chronic disease. 1 The SURMOUNT-5 study evaluated the safety and efficacy of tirzepatide compared with semaglutide over a period of approximately 74 weeks in adults with obesity or overweight with weight-related comorbidities without type 2 diabetes
Novo Nordisk reduced cash pricing for Wegovy and Ozempic to $349 monthly, down from the previous $499 rate
Safety and Side Effects Semaglutide, whether commercial or compounded, can cause side effects such as: Nausea Vomiting Diarrhea or constipation Fatigue Headache Serious (but rare) side effects may include: Pancreatitis Gallbladder disease Thyroid tumors (seen in animal studies) A gradual dose escalation and provider monitoring are critical to minimize risks
